Eric Crombez, M.D.

Eric Crombez, M.D.

Chief Medical Officer and Executive Vice PresidentatUltragenyx Pharmaceutical· In proxies 2024–2025

Pay in FY2025-7% from the year before · Ultragenyx Pharmaceutical stock -45.3% the same year

Eric Crombez, M.D. was paid $4.0M in FY2025 (Dec), down 7%. Ultragenyx Pharmaceutical stock fell 45.3% that year.

Pay$100 in the stock at the end of FY23 → $48
Pay is from the Summary Compensation Table of each Ultragenyx Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ultragenyx PharmaceuticalPublic company · 2 yr
    • Chief Medical Officer and Executive Vice President2024 – Present · 2 yrStock in role -64%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?